Gwynn D. Long

3.3k total citations
83 papers, 2.0k citations indexed

About

Gwynn D. Long is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Gwynn D. Long has authored 83 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 38 papers in Oncology and 15 papers in Immunology. Recurrent topics in Gwynn D. Long's work include Hematopoietic Stem Cell Transplantation (45 papers), Multiple Myeloma Research and Treatments (16 papers) and Polyomavirus and related diseases (11 papers). Gwynn D. Long is often cited by papers focused on Hematopoietic Stem Cell Transplantation (45 papers), Multiple Myeloma Research and Treatments (16 papers) and Polyomavirus and related diseases (11 papers). Gwynn D. Long collaborates with scholars based in United States, United Kingdom and Canada. Gwynn D. Long's co-authors include Nelson J. Chao, David A. Rizzieri, Sandra J. Horning, Cristina Gasparetto, Robert S. Negrin, Karl G. Blume, Mitchell E. Horwitz, Ruby M. Wong, Keith M. Sullivan and Richard T. Hoppe and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Gwynn D. Long

80 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gwynn D. Long United States 23 1.2k 759 542 487 403 83 2.0k
Barbara Sarina Italy 23 885 0.7× 700 0.9× 465 0.9× 530 1.1× 301 0.7× 76 1.7k
Cynthia L. Toze Canada 26 1.3k 1.1× 614 0.8× 388 0.7× 568 1.2× 685 1.7× 72 2.1k
Anne Parker United Kingdom 23 1.0k 0.9× 1.1k 1.5× 567 1.0× 768 1.6× 434 1.1× 54 2.6k
Diane Coso France 25 929 0.8× 582 0.8× 309 0.6× 376 0.8× 318 0.8× 78 1.7k
Görgün Akpek United States 25 1.1k 0.9× 465 0.6× 385 0.7× 296 0.6× 399 1.0× 65 2.0k
Louis Letendre United States 25 1.1k 0.9× 563 0.7× 399 0.7× 290 0.6× 490 1.2× 76 2.1k
Charles Linker United States 23 944 0.8× 657 0.9× 339 0.6× 241 0.5× 337 0.8× 58 2.1k
Edward Agura United States 22 1.6k 1.4× 1.1k 1.4× 858 1.6× 1.0k 2.1× 662 1.6× 49 2.9k
Taner Demirer Türkiye 31 2.2k 1.9× 1.2k 1.5× 763 1.4× 289 0.6× 512 1.3× 101 3.2k
F R Appelbaum United States 25 2.2k 1.8× 876 1.2× 655 1.2× 408 0.8× 479 1.2× 47 3.0k

Countries citing papers authored by Gwynn D. Long

Since Specialization
Citations

This map shows the geographic impact of Gwynn D. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gwynn D. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gwynn D. Long more than expected).

Fields of papers citing papers by Gwynn D. Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gwynn D. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gwynn D. Long. The network helps show where Gwynn D. Long may publish in the future.

Co-authorship network of co-authors of Gwynn D. Long

This figure shows the co-authorship network connecting the top 25 collaborators of Gwynn D. Long. A scholar is included among the top collaborators of Gwynn D. Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gwynn D. Long. Gwynn D. Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hussaini, S. M. Qasim, Yi Ren, Alessandro Racioppi, et al.. (2023). Financial toxicity and quality of life in patients undergoing bone marrow transplant evaluation: A single center analysis.. Journal of Clinical Oncology. 41(16_suppl). 7052–7052. 1 indexed citations
2.
Hussaini, S. M. Qasim, Yi Ren, Alessandro Racioppi, et al.. (2023). Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis. JCO Oncology Practice. 20(3). 351–360. 8 indexed citations
3.
Kang, Yubin, Pasupathi Sundaramoorthy, Cristina Gasparetto, et al.. (2022). Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma. Annals of Hematology. 102(2). 369–383. 11 indexed citations
4.
Lin, Chenyu, Edwin P. Alyea, Taewoong Choi, et al.. (2021). Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-up from a Single Center. Blood. 138(Supplement 1). 1827–1827. 1 indexed citations
5.
Ramalingam, Sendhilnathan, Mohammad Rauf Chaudhry, Yi Ren, et al.. (2020). Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality. PLoS ONE. 15(9). e0238824–e0238824. 4 indexed citations
6.
Sung, Anthony D., Carlos M. de Castro, Thomas W. LeBlanc, et al.. (2017). Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia. Blood. 130. 3853. 2 indexed citations
7.
Anand, Sarah, Samantha M. Thomas, Terry Hyslop, et al.. (2017). Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization. Biology of Blood and Marrow Transplantation. 23(7). 1151–1157. 27 indexed citations
8.
Anand, Sarah, Samantha M. Thomas, Kelly Corbet, et al.. (2017). Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning. Biology of Blood and Marrow Transplantation. 23(11). 1949–1954. 5 indexed citations
9.
Sivaraj, Dharshan, Michael Green, Zhiguo Li, et al.. (2016). Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 23(2). 262–268. 22 indexed citations
10.
Sung, Anthony D., Julia Sung, Samantha M. Thomas, et al.. (2016). Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial. Clinical Infectious Diseases. 63(8). 999–1006. 46 indexed citations
11.
Kanda, Junya, Gwynn D. Long, Cristina Gasparetto, et al.. (2013). Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 20(2). 257–263. 8 indexed citations
12.
Rizzieri, David A., Gwynn D. Long, Jon P. Gockerman, et al.. (2013). A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma. Cancer Investigation. 31(3). 172–176. 18 indexed citations
13.
Kanda, Junya, Paul Szabolcs, Gregory D. Sempowski, et al.. (2012). Immune Recovery in Adult Patients after Myeloablative Dual Umbilical Cord Blood, Matched Sibling, and Matched Unrelated Donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(11). 1664–1676.e1. 73 indexed citations
14.
Kanda, Junya, David A. Rizzieri, Cristina Gasparetto, et al.. (2010). Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350 cGy) and Fludarabine Conditioning. Biology of Blood and Marrow Transplantation. 17(6). 867–874. 23 indexed citations
15.
Horwitz, Mitchell E., David A. Rizzieri, Gwynn D. Long, et al.. (2006). Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival.. Blood. 108(11). 5399–5399. 1 indexed citations
16.
Rizzieri, David A., Dean McGaughey, Joseph O. Moore, et al.. (2004). Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma. Cancer. 100(11). 2408–2414. 15 indexed citations
17.
Long, Gwynn D., Mary Laughlin, Bella Madan, et al.. (2003). Unrelated umbilical cord blood transplantation in adult patients. Biology of Blood and Marrow Transplantation. 9(12). 772–780. 100 indexed citations
18.
Stuart, Monic J., Nelson J. Chao, Sandra J. Horning, et al.. (2001). Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. Biology of Blood and Marrow Transplantation. 7(10). 552–560. 17 indexed citations
19.
Long, Gwynn D., Nelson J. Chao, Wendy Hu, et al.. (1996). High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma. Cancer. 78(12). 2502–2509. 9 indexed citations
20.
Horning, Sandra J., Nelson J. Chao, Robert S. Negrin, et al.. (1991). The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: Preliminary data. Annals of Oncology. 2. 47–50. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026